| Login | Create Account | Leaders | Stock Exchange | News | How to Play |
| Soma Antibody | Don Bernardo, CEO | |||
|
Leader in worldwide biotechnology |
||||
| Quote: | Analyst Ratings: | |||
|---|---|---|---|---|
|
Intraday Price: Last Close: Symbol: Sector: Dividend Yield: Market Cap: Shares Float: Total Assets: Annual Earnings: Price/Earnings: Cash: |
$16,387.32 (+0.00%) $16,387.32 (+5.17%) SOMA Biotechnology 2.0% $819.37 billion 50.00 million $36.79 trillion $19.07 trillion 1.93 $4.41 trillion |
Goldsmith Maxx focuses on company cash, debt, dividend, liabilities, and legal proceedings. Goldsmith Maxx: Good KT Sorenson emphasizes revenue, profit, income, and cash flow. KT Sorenson: Excellent Jordin Gann observes company officers, management, operational efficiency, and direction. Jordin Gann: Excellent Walter Lane Financial projects future earnings based upon news and events. Walter Lane Financial: Excellent Harlin-Hall Group analyzes operating and profit margins and potential returns on equity and assets. Harlin-Hall Group: Excellent Solomon Stoan tracks business growth and expansion. Solomon Stoan: Good |
||
|
View Top Competitors |
||||